Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TENTACLES: a consensus machine learning tool for robust biomarker discovery in heterogeneous data.

BioData mining·2026
Same author

Establishment and application of a vesicle extraction method for clinical strains of <i>Pseudomonas aeruginosa</i>.

Microbiology spectrum·2026
Same author

<i>In vitro</i> cellular tropism and immunomodulatory response to rVSVΔG-ZEBOV-GP in human cells derived from tissues associated with adverse events.

Microbiology spectrum·2026
Same author

Correction: Long non-coding RNAs in response to Ebola virus vaccine-induced immunity.

Frontiers in immunology·2026
Same author

Long non-coding RNAs in response to Ebola virus vaccine-induced immunity.

Frontiers in immunology·2026
Same author

Immunogenicity evaluation of altSonflex1-2-3 <i>Shigella</i> vaccine across mice, rats, and rabbits to inform human translational insights.

Frontiers in immunology·2026
Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026
Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026
Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026
Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026
Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

ADITEC: joining forces for next-generation vaccines.

Rino Rappuoli1, Donata Medaglini

  • 1Novartis Vaccines and Diagnostics, 53100 Siena, Italy. rino.rappuoli@novartis.com

Science Translational Medicine
|April 12, 2012
PubMed
Summary
This summary is machine-generated.

Next-generation vaccine research, driven by genomics and immunology, faces complex challenges. A new collaborative model is needed to address sophisticated scientific and ethical issues in modern vaccine development.

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Related Experiment Videos

Last Updated: May 23, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • Genomics and systems biology have significantly advanced the understanding of human immunology.
  • Next-generation technologies, including adjuvant development and structure-based immunogen design, are revolutionizing vaccine research.
  • The complexity of modern vaccine science presents significant ethical challenges.

Purpose of the Study:

  • To highlight the transformative impact of new technologies on vaccinology.
  • To address the need for a new model in vaccine research due to scientific and ethical complexities.
  • To introduce the Advanced Immunization Technologies (ADITEC) project as a collaborative solution.

Main Methods:

  • Leveraging advances in genomics and systems biology for immunological insights.
  • Utilizing next-generation technologies such as adjuvant development and structure-based immunogen design.
  • Fostering collaboration among leading laboratories through the ADITEC project.

Main Results:

  • Significant advancements in understanding human immunology.
  • Transformation of the vaccine field with new technologies.
  • Identification of complex scientific and ethical issues requiring a new research model.

Conclusions:

  • The convergence of advanced technologies is reshaping vaccinology and medicine.
  • Current scientific and ethical complexities necessitate a novel approach to vaccine research.
  • Collaborative initiatives like ADITEC are crucial for tackling isolated research problems.